nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—FMO3—sweat—sclerosing cholangitis	0.132	0.212	CbGeAlD
Dasatinib—SRMS—gall bladder—sclerosing cholangitis	0.0383	0.0617	CbGeAlD
Dasatinib—TEC—liver—sclerosing cholangitis	0.0178	0.0287	CbGeAlD
Dasatinib—STAT5B—pancreas—sclerosing cholangitis	0.0163	0.0263	CbGeAlD
Dasatinib—PDGFRA—gall bladder—sclerosing cholangitis	0.0163	0.0263	CbGeAlD
Dasatinib—EPHB1—liver—sclerosing cholangitis	0.014	0.0225	CbGeAlD
Dasatinib—KIT—gall bladder—sclerosing cholangitis	0.0131	0.021	CbGeAlD
Dasatinib—PDGFRB—gall bladder—sclerosing cholangitis	0.0128	0.0205	CbGeAlD
Dasatinib—SIK2—liver—sclerosing cholangitis	0.0123	0.0199	CbGeAlD
Dasatinib—FRK—liver—sclerosing cholangitis	0.012	0.0194	CbGeAlD
Dasatinib—STK35—pancreas—sclerosing cholangitis	0.0111	0.0179	CbGeAlD
Dasatinib—CSK—pancreas—sclerosing cholangitis	0.0111	0.0178	CbGeAlD
Dasatinib—STAT5B—liver—sclerosing cholangitis	0.0104	0.0168	CbGeAlD
Dasatinib—SIK1—pancreas—sclerosing cholangitis	0.01	0.0162	CbGeAlD
Dasatinib—ERBB3—pancreas—sclerosing cholangitis	0.00983	0.0158	CbGeAlD
Dasatinib—SIK3—liver—sclerosing cholangitis	0.00935	0.0151	CbGeAlD
Dasatinib—ZAK—liver—sclerosing cholangitis	0.0087	0.014	CbGeAlD
Dasatinib—EPHB4—pancreas—sclerosing cholangitis	0.00868	0.014	CbGeAlD
Dasatinib—EPHA2—pancreas—sclerosing cholangitis	0.00851	0.0137	CbGeAlD
Dasatinib—LYN—liver—sclerosing cholangitis	0.00847	0.0136	CbGeAlD
Dasatinib—MAP4K5—pancreas—sclerosing cholangitis	0.00831	0.0134	CbGeAlD
Dasatinib—BTK—liver—sclerosing cholangitis	0.0083	0.0134	CbGeAlD
Dasatinib—TNK2—liver—sclerosing cholangitis	0.00818	0.0132	CbGeAlD
Dasatinib—TESK1—liver—sclerosing cholangitis	0.00769	0.0124	CbGeAlD
Dasatinib—YES1—pancreas—sclerosing cholangitis	0.00767	0.0124	CbGeAlD
Dasatinib—STK36—liver—sclerosing cholangitis	0.00756	0.0122	CbGeAlD
Dasatinib—SRC—pancreas—sclerosing cholangitis	0.00738	0.0119	CbGeAlD
Dasatinib—LIMK2—liver—sclerosing cholangitis	0.00731	0.0118	CbGeAlD
Dasatinib—STK35—liver—sclerosing cholangitis	0.00709	0.0114	CbGeAlD
Dasatinib—CSK—liver—sclerosing cholangitis	0.00704	0.0113	CbGeAlD
Dasatinib—HCK—liver—sclerosing cholangitis	0.00695	0.0112	CbGeAlD
Dasatinib—ABL2—liver—sclerosing cholangitis	0.00691	0.0111	CbGeAlD
Dasatinib—RIPK2—liver—sclerosing cholangitis	0.00654	0.0105	CbGeAlD
Dasatinib—SIK1—liver—sclerosing cholangitis	0.00638	0.0103	CbGeAlD
Dasatinib—ERBB3—liver—sclerosing cholangitis	0.00626	0.0101	CbGeAlD
Dasatinib—MAP3K2—liver—sclerosing cholangitis	0.0062	0.00998	CbGeAlD
Dasatinib—KIT—pancreas—sclerosing cholangitis	0.00602	0.00969	CbGeAlD
Dasatinib—PDGFRB—pancreas—sclerosing cholangitis	0.00588	0.00946	CbGeAlD
Dasatinib—MAPK14—liver—sclerosing cholangitis	0.00583	0.00938	CbGeAlD
Dasatinib—LCK—liver—sclerosing cholangitis	0.0058	0.00934	CbGeAlD
Dasatinib—FGR—liver—sclerosing cholangitis	0.0058	0.00934	CbGeAlD
Dasatinib—FMO3—liver—sclerosing cholangitis	0.0056	0.00902	CbGeAlD
Dasatinib—EPHB4—liver—sclerosing cholangitis	0.00552	0.00889	CbGeAlD
Dasatinib—JAK2—liver—sclerosing cholangitis	0.00548	0.00883	CbGeAlD
Dasatinib—EPHA2—liver—sclerosing cholangitis	0.00542	0.00872	CbGeAlD
Dasatinib—FYN—liver—sclerosing cholangitis	0.00541	0.00871	CbGeAlD
Dasatinib—MAP4K5—liver—sclerosing cholangitis	0.00529	0.00851	CbGeAlD
Dasatinib—MAP3K3—liver—sclerosing cholangitis	0.00529	0.00851	CbGeAlD
Dasatinib—ABL1—pancreas—sclerosing cholangitis	0.00524	0.00843	CbGeAlD
Dasatinib—YES1—liver—sclerosing cholangitis	0.00488	0.00786	CbGeAlD
Dasatinib—PDGFRA—liver—sclerosing cholangitis	0.00479	0.00771	CbGeAlD
Dasatinib—SRC—liver—sclerosing cholangitis	0.0047	0.00756	CbGeAlD
Dasatinib—BLK—Apoptosis Modulation and Signaling—BCL2L11—sclerosing cholangitis	0.0046	0.0121	CbGpPWpGaD
Dasatinib—MAP3K2—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00458	0.0121	CbGpPWpGaD
Dasatinib—STAT5B—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00444	0.0117	CbGpPWpGaD
Dasatinib—MAP2K5—liver—sclerosing cholangitis	0.00432	0.00696	CbGeAlD
Dasatinib—CSF1R—liver—sclerosing cholangitis	0.00422	0.00679	CbGeAlD
Dasatinib—ABL1—ErbB Signaling Pathway—BCL2L11—sclerosing cholangitis	0.00417	0.011	CbGpPWpGaD
Dasatinib—MAP3K2—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00404	0.0107	CbGpPWpGaD
Dasatinib—STAT5B—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00392	0.0103	CbGpPWpGaD
Dasatinib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00388	0.0102	CbGpPWpGaD
Dasatinib—PDGFRA—Angiogenesis—HIF1A—sclerosing cholangitis	0.00387	0.0102	CbGpPWpGaD
Dasatinib—KIT—liver—sclerosing cholangitis	0.00383	0.00616	CbGeAlD
Dasatinib—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.00381	0.0101	CbGpPWpGaD
Dasatinib—PDGFRB—liver—sclerosing cholangitis	0.00374	0.00602	CbGeAlD
Dasatinib—STAT5B—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.00357	0.00941	CbGpPWpGaD
Dasatinib—STAT5B—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.00352	0.0093	CbGpPWpGaD
Dasatinib—CYP3A5—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00336	0.00887	CbGpPWpGaD
Dasatinib—ABL1—liver—sclerosing cholangitis	0.00333	0.00537	CbGeAlD
Dasatinib—EPHA3—NRF2 pathway—GGT1—sclerosing cholangitis	0.00326	0.0086	CbGpPWpGaD
Dasatinib—MAPK14—Angiogenesis—HIF1A—sclerosing cholangitis	0.00323	0.00853	CbGpPWpGaD
Dasatinib—EPHB1—Developmental Biology—TCF4—sclerosing cholangitis	0.00321	0.00847	CbGpPWpGaD
Dasatinib—STAT5B—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.00321	0.00846	CbGpPWpGaD
Dasatinib—STAT5B—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.00317	0.00836	CbGpPWpGaD
Dasatinib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0031	0.00818	CbGpPWpGaD
Dasatinib—ABL1—p73 transcription factor network—BCL2L11—sclerosing cholangitis	0.00308	0.00812	CbGpPWpGaD
Dasatinib—CYP3A5—pancreas—sclerosing cholangitis	0.00307	0.00494	CbGeAlD
Dasatinib—SRC—ErbB Signaling Pathway—BCL2L11—sclerosing cholangitis	0.00304	0.00802	CbGpPWpGaD
Dasatinib—MAP2K5—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00303	0.008	CbGpPWpGaD
Dasatinib—MAPK14—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.00298	0.00787	CbGpPWpGaD
Dasatinib—JAK2—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.00295	0.00777	CbGpPWpGaD
Dasatinib—MAPK14—p73 transcription factor network—BCL2L11—sclerosing cholangitis	0.00293	0.00773	CbGpPWpGaD
Dasatinib—CYP1B1—liver—sclerosing cholangitis	0.00282	0.00454	CbGeAlD
Dasatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00274	0.00724	CbGpPWpGaD
Dasatinib—MAP2K5—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00267	0.00705	CbGpPWpGaD
Dasatinib—SIK1—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.00265	0.007	CbGpPWpGaD
Dasatinib—RIPK2—IL12-mediated signaling events—NOS2—sclerosing cholangitis	0.00258	0.00682	CbGpPWpGaD
Dasatinib—EPHA2—NRF2 pathway—GGT1—sclerosing cholangitis	0.00253	0.00669	CbGpPWpGaD
Dasatinib—MAPK14—Corticotropin-releasing hormone—TCF4—sclerosing cholangitis	0.00249	0.00658	CbGpPWpGaD
Dasatinib—SRC—Angiogenesis—HIF1A—sclerosing cholangitis	0.00247	0.00653	CbGpPWpGaD
Dasatinib—ABL1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00241	0.00635	CbGpPWpGaD
Dasatinib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00239	0.00631	CbGpPWpGaD
Dasatinib—CYP1B1—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00238	0.00628	CbGpPWpGaD
Dasatinib—ABL1—DNA Damage Response (only ATM dependent)—BCL2L11—sclerosing cholangitis	0.00238	0.00627	CbGpPWpGaD
Dasatinib—EPHA4—Spinal Cord Injury—NOS2—sclerosing cholangitis	0.00233	0.00616	CbGpPWpGaD
Dasatinib—MAPK14—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00229	0.00605	CbGpPWpGaD
Dasatinib—SRC—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.00228	0.00603	CbGpPWpGaD
Dasatinib—SRC—Alpha9 beta1 integrin signaling events—NOS2—sclerosing cholangitis	0.00218	0.00575	CbGpPWpGaD
Dasatinib—MAPK14—Signaling mediated by p38-alpha and p38-beta—NOS2—sclerosing cholangitis	0.00217	0.00574	CbGpPWpGaD
Dasatinib—EPHB3—Developmental Biology—TCF4—sclerosing cholangitis	0.00217	0.00572	CbGpPWpGaD
Dasatinib—ABCG2—liver—sclerosing cholangitis	0.0021	0.00338	CbGeAlD
Dasatinib—JAK2—Type II interferon signaling (IFNG)—NOS2—sclerosing cholangitis	0.00205	0.00542	CbGpPWpGaD
Dasatinib—JAK2—IL23-mediated signaling events—NOS2—sclerosing cholangitis	0.00205	0.00542	CbGpPWpGaD
Dasatinib—STAT5B—Adipogenesis—HIF1A—sclerosing cholangitis	0.00205	0.00541	CbGpPWpGaD
Dasatinib—CYP1A2—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00202	0.00534	CbGpPWpGaD
Dasatinib—CYP1A2—liver—sclerosing cholangitis	0.00202	0.00326	CbGeAlD
Dasatinib—FGR—Platelet homeostasis—NOS2—sclerosing cholangitis	0.00201	0.0053	CbGpPWpGaD
Dasatinib—CYP1A1—liver—sclerosing cholangitis	0.002	0.00321	CbGeAlD
Dasatinib—FMO3—Biological oxidations—GGT1—sclerosing cholangitis	0.00197	0.0052	CbGpPWpGaD
Dasatinib—CYP3A5—liver—sclerosing cholangitis	0.00195	0.00314	CbGeAlD
Dasatinib—EPHA3—Developmental Biology—TCF4—sclerosing cholangitis	0.00193	0.0051	CbGpPWpGaD
Dasatinib—ABL2—Developmental Biology—TCF4—sclerosing cholangitis	0.00193	0.0051	CbGpPWpGaD
Dasatinib—EPHA5—Developmental Biology—TCF4—sclerosing cholangitis	0.00193	0.0051	CbGpPWpGaD
Dasatinib—RIPK2—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00191	0.00505	CbGpPWpGaD
Dasatinib—CYP1A1—PPARA activates gene expression—ABCB4—sclerosing cholangitis	0.0019	0.00501	CbGpPWpGaD
Dasatinib—FYN—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00188	0.00497	CbGpPWpGaD
Dasatinib—JAK2—Notch-mediated HES/HEY network—HIF1A—sclerosing cholangitis	0.00186	0.00492	CbGpPWpGaD
Dasatinib—EPHA8—Developmental Biology—TCF4—sclerosing cholangitis	0.00186	0.00492	CbGpPWpGaD
Dasatinib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCB4—sclerosing cholangitis	0.00186	0.00491	CbGpPWpGaD
Dasatinib—EPHB4—Developmental Biology—TCF4—sclerosing cholangitis	0.00184	0.00486	CbGpPWpGaD
Dasatinib—EPHA4—Developmental Biology—TCF4—sclerosing cholangitis	0.00184	0.00486	CbGpPWpGaD
Dasatinib—LIMK2—Developmental Biology—TCF4—sclerosing cholangitis	0.00184	0.00486	CbGpPWpGaD
Dasatinib—MAPK14—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00181	0.00478	CbGpPWpGaD
Dasatinib—JAK2—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00179	0.00472	CbGpPWpGaD
Dasatinib—EPHB2—Developmental Biology—TCF4—sclerosing cholangitis	0.00178	0.00471	CbGpPWpGaD
Dasatinib—SRC—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00175	0.00463	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00175	0.00462	CbGpPWpGaD
Dasatinib—EPHB6—Developmental Biology—TCF4—sclerosing cholangitis	0.00173	0.00457	CbGpPWpGaD
Dasatinib—PDGFRA—ATF-2 transcription factor network—NOS2—sclerosing cholangitis	0.00171	0.00452	CbGpPWpGaD
Dasatinib—ERBB3—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00169	0.00445	CbGpPWpGaD
Dasatinib—FYN—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00166	0.00438	CbGpPWpGaD
Dasatinib—ABCB1—pancreas—sclerosing cholangitis	0.00163	0.00262	CbGeAlD
Dasatinib—MAPK14—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.0016	0.00422	CbGpPWpGaD
Dasatinib—JAK2—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00158	0.00416	CbGpPWpGaD
Dasatinib—CYP3A4—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00156	0.00412	CbGpPWpGaD
Dasatinib—JAK2—Notch Signaling Pathway—HIF1A—sclerosing cholangitis	0.00151	0.00399	CbGpPWpGaD
Dasatinib—EPHA2—Developmental Biology—TCF4—sclerosing cholangitis	0.0015	0.00396	CbGpPWpGaD
Dasatinib—FMO3—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.00148	0.00391	CbGpPWpGaD
Dasatinib—CYP1A1—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00146	0.00386	CbGpPWpGaD
Dasatinib—CYP3A4—liver—sclerosing cholangitis	0.00146	0.00236	CbGeAlD
Dasatinib—MAPK14—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.00146	0.00384	CbGpPWpGaD
Dasatinib—MAPK14—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.00144	0.0038	CbGpPWpGaD
Dasatinib—JAK2—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.00144	0.00379	CbGpPWpGaD
Dasatinib—MAPK14—ATF-2 transcription factor network—NOS2—sclerosing cholangitis	0.00143	0.00378	CbGpPWpGaD
Dasatinib—JAK2—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.00142	0.00375	CbGpPWpGaD
Dasatinib—MAPK14—IL12-mediated signaling events—NOS2—sclerosing cholangitis	0.00141	0.00373	CbGpPWpGaD
Dasatinib—JAK2—IL12-mediated signaling events—NOS2—sclerosing cholangitis	0.00139	0.00368	CbGpPWpGaD
Dasatinib—SRC—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00139	0.00366	CbGpPWpGaD
Dasatinib—LCK—Notch Signaling Pathway—HIF1A—sclerosing cholangitis	0.00133	0.0035	CbGpPWpGaD
Dasatinib—KIT—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00132	0.00349	CbGpPWpGaD
Dasatinib—MAPK14—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.00131	0.00345	CbGpPWpGaD
Dasatinib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.00129	0.00341	CbGpPWpGaD
Dasatinib—JAK2—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.00129	0.00341	CbGpPWpGaD
Dasatinib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—sclerosing cholangitis	0.00128	0.00338	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00125	0.0033	CbGpPWpGaD
Dasatinib—SRC—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00122	0.00323	CbGpPWpGaD
Dasatinib—LCK—IL12-mediated signaling events—NOS2—sclerosing cholangitis	0.00122	0.00322	CbGpPWpGaD
Dasatinib—ABCG2—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.00121	0.00318	CbGpPWpGaD
Dasatinib—SRC—Notch Signaling Pathway—HIF1A—sclerosing cholangitis	0.00117	0.0031	CbGpPWpGaD
Dasatinib—MAPK14—Platelet homeostasis—NOS2—sclerosing cholangitis	0.00115	0.00302	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00113	0.00298	CbGpPWpGaD
Dasatinib—SRC—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.00112	0.00294	CbGpPWpGaD
Dasatinib—SRC—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.0011	0.00291	CbGpPWpGaD
Dasatinib—ABCG2—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.0011	0.00289	CbGpPWpGaD
Dasatinib—FYN—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00109	0.00287	CbGpPWpGaD
Dasatinib—MAPK14—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00105	0.00276	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00104	0.00274	CbGpPWpGaD
Dasatinib—ABCB1—liver—sclerosing cholangitis	0.00104	0.00167	CbGeAlD
Dasatinib—JAK2—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00103	0.00273	CbGpPWpGaD
Dasatinib—SRC—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.001	0.00264	CbGpPWpGaD
Dasatinib—SRC—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.00099	0.00261	CbGpPWpGaD
Dasatinib—CYP1A2—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.000934	0.00246	CbGpPWpGaD
Dasatinib—YES1—Developmental Biology—TCF4—sclerosing cholangitis	0.000919	0.00242	CbGpPWpGaD
Dasatinib—LCK—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.000905	0.00239	CbGpPWpGaD
Dasatinib—ABCG2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000897	0.00237	CbGpPWpGaD
Dasatinib—CYP1B1—Biological oxidations—GGT1—sclerosing cholangitis	0.000885	0.00234	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000829	0.00219	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—ABCB4—sclerosing cholangitis	0.000822	0.00217	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000807	0.00213	CbGpPWpGaD
Dasatinib—SRC—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.000801	0.00211	CbGpPWpGaD
Dasatinib—LYN—Developmental Biology—TCF4—sclerosing cholangitis	0.000685	0.00181	CbGpPWpGaD
Dasatinib—ABL1—Developmental Biology—TCF4—sclerosing cholangitis	0.000682	0.0018	CbGpPWpGaD
Dasatinib—FYN—Developmental Biology—TCF4—sclerosing cholangitis	0.000675	0.00178	CbGpPWpGaD
Dasatinib—ABCB1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.000652	0.00172	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—TCF4—sclerosing cholangitis	0.00065	0.00171	CbGpPWpGaD
Dasatinib—CSK—Hemostasis—NOS2—sclerosing cholangitis	0.000649	0.00171	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—TCF4—sclerosing cholangitis	0.000641	0.00169	CbGpPWpGaD
Dasatinib—CYP1A2—Phase II conjugation—GGT1—sclerosing cholangitis	0.000594	0.00157	CbGpPWpGaD
Dasatinib—ABCB1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.000593	0.00156	CbGpPWpGaD
Dasatinib—CYP3A5—Biological oxidations—GGT1—sclerosing cholangitis	0.000577	0.00152	CbGpPWpGaD
Dasatinib—CSK—Disease—GOT2—sclerosing cholangitis	0.000575	0.00152	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000568	0.0015	CbGpPWpGaD
Dasatinib—STAT5B—Disease—GOT2—sclerosing cholangitis	0.000557	0.00147	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000551	0.00145	CbGpPWpGaD
Dasatinib—CYP1A1—Biological oxidations—GGT1—sclerosing cholangitis	0.000545	0.00144	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00051	0.00135	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—TCF4—sclerosing cholangitis	0.000497	0.00131	CbGpPWpGaD
Dasatinib—CSK—Disease—GOT1—sclerosing cholangitis	0.000496	0.00131	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000485	0.00128	CbGpPWpGaD
Dasatinib—STAT5B—Disease—GOT1—sclerosing cholangitis	0.000481	0.00127	CbGpPWpGaD
Dasatinib—MAPK14—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.000475	0.00125	CbGpPWpGaD
Dasatinib—FGR—Hemostasis—NOS2—sclerosing cholangitis	0.00045	0.00119	CbGpPWpGaD
Dasatinib—HCK—Disease—GOT2—sclerosing cholangitis	0.000441	0.00116	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000411	0.00108	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—GOT2—sclerosing cholangitis	0.000391	0.00103	CbGpPWpGaD
Dasatinib—HCK—Disease—GOT1—sclerosing cholangitis	0.000381	0.00101	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000376	0.000992	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—ABCB4—sclerosing cholangitis	0.000369	0.000974	CbGpPWpGaD
Dasatinib—ERBB3—Disease—GOT2—sclerosing cholangitis	0.000366	0.000967	CbGpPWpGaD
Dasatinib—YES1—Hemostasis—NOS2—sclerosing cholangitis	0.000363	0.000958	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000362	0.000956	CbGpPWpGaD
Dasatinib—CYP1A2—Biological oxidations—GGT1—sclerosing cholangitis	0.000348	0.000917	CbGpPWpGaD
Dasatinib—CSK—Disease—HIF1A—sclerosing cholangitis	0.000345	0.000911	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000343	0.000906	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00034	0.000897	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—GGT1—sclerosing cholangitis	0.000337	0.00089	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—GOT1—sclerosing cholangitis	0.000337	0.00089	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—ABCB4—sclerosing cholangitis	0.000336	0.000886	CbGpPWpGaD
Dasatinib—STAT5B—Disease—HIF1A—sclerosing cholangitis	0.000334	0.000883	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000325	0.000859	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000318	0.000839	CbGpPWpGaD
Dasatinib—ERBB3—Disease—GOT1—sclerosing cholangitis	0.000316	0.000835	CbGpPWpGaD
Dasatinib—CSK—Disease—NOS2—sclerosing cholangitis	0.000314	0.000829	CbGpPWpGaD
Dasatinib—STAT5B—Disease—NOS2—sclerosing cholangitis	0.000304	0.000803	CbGpPWpGaD
Dasatinib—KIT—Disease—GOT2—sclerosing cholangitis	0.000287	0.000758	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000284	0.00075	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—GOT2—sclerosing cholangitis	0.000272	0.000718	CbGpPWpGaD
Dasatinib—LYN—Hemostasis—NOS2—sclerosing cholangitis	0.000271	0.000714	CbGpPWpGaD
Dasatinib—ABL1—Hemostasis—NOS2—sclerosing cholangitis	0.000269	0.000711	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000269	0.00071	CbGpPWpGaD
Dasatinib—CYP3A4—Biological oxidations—GGT1—sclerosing cholangitis	0.000268	0.000708	CbGpPWpGaD
Dasatinib—FYN—Hemostasis—NOS2—sclerosing cholangitis	0.000266	0.000703	CbGpPWpGaD
Dasatinib—HCK—Disease—HIF1A—sclerosing cholangitis	0.000265	0.000699	CbGpPWpGaD
Dasatinib—MAPK14—Hemostasis—NOS2—sclerosing cholangitis	0.000257	0.000677	CbGpPWpGaD
Dasatinib—JAK2—Hemostasis—NOS2—sclerosing cholangitis	0.000253	0.000668	CbGpPWpGaD
Dasatinib—KIT—Disease—GOT1—sclerosing cholangitis	0.000248	0.000654	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—GOT2—sclerosing cholangitis	0.000245	0.000647	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000242	0.000639	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000242	0.000638	CbGpPWpGaD
Dasatinib—HCK—Disease—NOS2—sclerosing cholangitis	0.000241	0.000636	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ABCB4—sclerosing cholangitis	0.000241	0.000635	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000237	0.000626	CbGpPWpGaD
Dasatinib—FYN—Disease—GOT2—sclerosing cholangitis	0.000236	0.000623	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—GOT1—sclerosing cholangitis	0.000235	0.000619	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000234	0.000618	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000233	0.000616	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ABCB4—sclerosing cholangitis	0.000227	0.0006	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000225	0.000593	CbGpPWpGaD
Dasatinib—JAK2—Disease—GOT2—sclerosing cholangitis	0.000224	0.000592	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000222	0.000586	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—NOS2—sclerosing cholangitis	0.000222	0.000585	CbGpPWpGaD
Dasatinib—ERBB3—Disease—HIF1A—sclerosing cholangitis	0.00022	0.000581	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—GOT1—sclerosing cholangitis	0.000211	0.000558	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000209	0.000552	CbGpPWpGaD
Dasatinib—FYN—Disease—GOT1—sclerosing cholangitis	0.000204	0.000538	CbGpPWpGaD
Dasatinib—ERBB3—Disease—NOS2—sclerosing cholangitis	0.0002	0.000528	CbGpPWpGaD
Dasatinib—LCK—Disease—GOT2—sclerosing cholangitis	0.000197	0.000519	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—NOS2—sclerosing cholangitis	0.000196	0.000518	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000194	0.000513	CbGpPWpGaD
Dasatinib—JAK2—Disease—GOT1—sclerosing cholangitis	0.000194	0.000511	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ABCB4—sclerosing cholangitis	0.000182	0.000479	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—GOT2—sclerosing cholangitis	0.000175	0.000463	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000175	0.000461	CbGpPWpGaD
Dasatinib—SRC—Disease—GOT2—sclerosing cholangitis	0.000174	0.000459	CbGpPWpGaD
Dasatinib—KIT—Disease—HIF1A—sclerosing cholangitis	0.000173	0.000455	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000172	0.000454	CbGpPWpGaD
Dasatinib—LCK—Disease—GOT1—sclerosing cholangitis	0.00017	0.000448	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—HIF1A—sclerosing cholangitis	0.000163	0.000431	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—HIF1A—sclerosing cholangitis	0.00016	0.000422	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—GOT2—sclerosing cholangitis	0.00016	0.000421	CbGpPWpGaD
Dasatinib—KIT—Disease—NOS2—sclerosing cholangitis	0.000157	0.000414	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000154	0.000407	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—GOT1—sclerosing cholangitis	0.000151	0.000399	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—GGT1—sclerosing cholangitis	0.000151	0.000399	CbGpPWpGaD
Dasatinib—SRC—Disease—GOT1—sclerosing cholangitis	0.00015	0.000396	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—NOS2—sclerosing cholangitis	0.000149	0.000392	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—HIF1A—sclerosing cholangitis	0.000147	0.000388	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ABCB4—sclerosing cholangitis	0.000145	0.000382	CbGpPWpGaD
Dasatinib—FYN—Disease—HIF1A—sclerosing cholangitis	0.000142	0.000374	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—GGT1—sclerosing cholangitis	0.000138	0.000363	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—GOT1—sclerosing cholangitis	0.000138	0.000363	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000135	0.000357	CbGpPWpGaD
Dasatinib—JAK2—Disease—HIF1A—sclerosing cholangitis	0.000135	0.000356	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—NOS2—sclerosing cholangitis	0.000134	0.000353	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000133	0.000352	CbGpPWpGaD
Dasatinib—FYN—Disease—NOS2—sclerosing cholangitis	0.000129	0.00034	CbGpPWpGaD
Dasatinib—JAK2—Disease—NOS2—sclerosing cholangitis	0.000123	0.000324	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000121	0.000319	CbGpPWpGaD
Dasatinib—LCK—Disease—HIF1A—sclerosing cholangitis	0.000118	0.000312	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000114	0.000302	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—GOT2—sclerosing cholangitis	0.000114	0.000302	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ABCB4—sclerosing cholangitis	0.000112	0.000295	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GOT2—sclerosing cholangitis	0.000108	0.000285	CbGpPWpGaD
Dasatinib—LCK—Disease—NOS2—sclerosing cholangitis	0.000107	0.000283	CbGpPWpGaD
Dasatinib—SRC—Disease—HIF1A—sclerosing cholangitis	0.000105	0.000276	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000103	0.000272	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000101	0.000266	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—HIF1A—sclerosing cholangitis	9.93e-05	0.000262	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—GGT1—sclerosing cholangitis	9.87e-05	0.00026	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—GOT1—sclerosing cholangitis	9.87e-05	0.00026	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—HIF1A—sclerosing cholangitis	9.56e-05	0.000252	CbGpPWpGaD
Dasatinib—SRC—Disease—NOS2—sclerosing cholangitis	9.51e-05	0.000251	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—HIF1A—sclerosing cholangitis	9.44e-05	0.000249	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GGT1—sclerosing cholangitis	9.32e-05	0.000246	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GOT1—sclerosing cholangitis	9.32e-05	0.000246	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GOT2—sclerosing cholangitis	8.62e-05	0.000228	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—HIF1A—sclerosing cholangitis	8.27e-05	0.000218	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GOT1—sclerosing cholangitis	7.44e-05	0.000196	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GGT1—sclerosing cholangitis	7.44e-05	0.000196	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—HIF1A—sclerosing cholangitis	7.32e-05	0.000193	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GOT2—sclerosing cholangitis	6.89e-05	0.000182	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GOT1—sclerosing cholangitis	5.94e-05	0.000157	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GGT1—sclerosing cholangitis	5.94e-05	0.000157	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GOT2—sclerosing cholangitis	5.31e-05	0.00014	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GGT1—sclerosing cholangitis	4.59e-05	0.000121	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GOT1—sclerosing cholangitis	4.59e-05	0.000121	CbGpPWpGaD
